[Radiation protective effect of low molecular weight thymus preparations]. 1994

V A Baraboĭ, and S I Ialkut, and Z D Savtsova, and V A Zinchenko, and V M Zhukova, and M Iu Zaritskaia

The antiradiation efficiency of low molecular thymic preparations (vilosen, thymogen) was determined. The therapeutic activity of thymic preparations is due to their influence on basic radiation injury syndromes (hemopoietic, gastrointestinal, immunodepressive). The protective mechanisms and perspectives of thymic preparations using in pathogenic therapy of radiation diseases are discussed.

UI MeSH Term Description Entries
D007413 Intestinal Mucosa Lining of the INTESTINES, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. In the SMALL INTESTINE, the mucosa is characterized by a series of folds and abundance of absorptive cells (ENTEROCYTES) with MICROVILLI. Intestinal Epithelium,Intestinal Glands,Epithelium, Intestinal,Gland, Intestinal,Glands, Intestinal,Intestinal Gland,Mucosa, Intestinal
D008297 Male Males
D008938 Mitosis A type of CELL NUCLEUS division by means of which the two daughter nuclei normally receive identical complements of the number of CHROMOSOMES of the somatic cells of the species. M Phase, Mitotic,Mitotic M Phase,M Phases, Mitotic,Mitoses,Mitotic M Phases,Phase, Mitotic M,Phases, Mitotic M
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D011833 Radiation Injuries, Experimental Experimentally produced harmful effects of ionizing or non-ionizing RADIATION in CHORDATA animals. Experimental Radiation Injuries,Injuries, Experimental Radiation,Experimental Radiation Injury,Radiation Injury, Experimental
D011837 Radiation-Protective Agents Drugs used to protect against ionizing radiation. They are usually of interest for use in radiation therapy but have been considered for other purposes, e.g. military. Radiation Protectant,Radiation Protective Agent,Radiation-Protective Agent,Radiation-Protective Drug,Radioprotective Agent,Radioprotective Agents,Radioprotective Drug,Agents, Radiation-Protective,Radiation Protectants,Radiation Protective Agents,Radiation-Protective Drugs,Radiation-Protective Effect,Radiation-Protective Effects,Radioprotective Drugs,Agent, Radiation Protective,Agent, Radiation-Protective,Agent, Radioprotective,Agents, Radiation Protective,Agents, Radioprotective,Drug, Radiation-Protective,Drug, Radioprotective,Drugs, Radiation-Protective,Drugs, Radioprotective,Effect, Radiation-Protective,Effects, Radiation-Protective,Protectant, Radiation,Protectants, Radiation,Protective Agent, Radiation,Protective Agents, Radiation,Radiation Protective Drug,Radiation Protective Drugs,Radiation Protective Effect,Radiation Protective Effects
D001772 Blood Cell Count The number of LEUKOCYTES and ERYTHROCYTES per unit volume in a sample of venous BLOOD. A complete blood count (CBC) also includes measurement of the HEMOGLOBIN; HEMATOCRIT; and ERYTHROCYTE INDICES. Blood Cell Number,Blood Count, Complete,Blood Cell Counts,Blood Cell Numbers,Blood Counts, Complete,Complete Blood Count,Complete Blood Counts,Count, Blood Cell,Count, Complete Blood,Counts, Blood Cell,Counts, Complete Blood,Number, Blood Cell,Numbers, Blood Cell
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D004151 Dipeptides Peptides composed of two amino acid units. Dipeptide
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants

Related Publications

V A Baraboĭ, and S I Ialkut, and Z D Savtsova, and V A Zinchenko, and V M Zhukova, and M Iu Zaritskaia
January 1980, Acta biochimica Polonica,
V A Baraboĭ, and S I Ialkut, and Z D Savtsova, and V A Zinchenko, and V M Zhukova, and M Iu Zaritskaia
January 1958, Vestnik Akademii meditsinskikh nauk SSSR,
V A Baraboĭ, and S I Ialkut, and Z D Savtsova, and V A Zinchenko, and V M Zhukova, and M Iu Zaritskaia
February 1965, JAMA,
V A Baraboĭ, and S I Ialkut, and Z D Savtsova, and V A Zinchenko, and V M Zhukova, and M Iu Zaritskaia
May 1981, Canadian journal of biochemistry,
V A Baraboĭ, and S I Ialkut, and Z D Savtsova, and V A Zinchenko, and V M Zhukova, and M Iu Zaritskaia
July 1978, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
V A Baraboĭ, and S I Ialkut, and Z D Savtsova, and V A Zinchenko, and V M Zhukova, and M Iu Zaritskaia
January 1985, Seminars in thrombosis and hemostasis,
V A Baraboĭ, and S I Ialkut, and Z D Savtsova, and V A Zinchenko, and V M Zhukova, and M Iu Zaritskaia
November 1997, Annals of the New York Academy of Sciences,
V A Baraboĭ, and S I Ialkut, and Z D Savtsova, and V A Zinchenko, and V M Zhukova, and M Iu Zaritskaia
January 2018, Journal of radiation research,
V A Baraboĭ, and S I Ialkut, and Z D Savtsova, and V A Zinchenko, and V M Zhukova, and M Iu Zaritskaia
November 2001, Zhonghua yi xue za zhi,
V A Baraboĭ, and S I Ialkut, and Z D Savtsova, and V A Zinchenko, and V M Zhukova, and M Iu Zaritskaia
January 2019, Marine drugs,
Copied contents to your clipboard!